IVIG is recognized as a valuable tool in toxicology, particularly in cases where standard treatments are insufficient or contraindicated. Its use is supported by clinical evidence in specific scenarios, although it is not a universal remedy for all toxic exposures. As with all treatments, the decision to use IVIG should be based on a comprehensive assessment of the individual patient's needs and the specific toxicological context.
In conclusion, immunoglobulin therapy represents a significant advancement in the management of certain toxicological conditions. Its role in immune modulation and toxin neutralization makes it a versatile option in the toxicologist's toolkit, offering hope for improved outcomes in complex cases.
